Overview

Basal-bolus and Premixed Insulin Regimens in Hospitalized Patients With Type 2 Diabetes (PININ Study)

Status:
Terminated

Trial end date:
2014-02-01

Target enrollment:

Participant gender:

Summary

Pilot study to compare the efficacy and safety of a premixed-insulin regimen (70% intermediate insulin and 30% regular insulin) to a basal-bolus insulin regimen (glargine once daily and glulisine before meals) hospitalized patients with type 2 diabetes.

Phase:

Phase 4

Details

Lead Sponsor:

Hospital Universitario Central de Asturias

Collaborator:

Sanofi

Treatments:

Insulin
Insulin Glargine
Insulin glulisine
Insulin, Globin Zinc
Insulin, pork; isophane insulin, pork drug combination 30:70